Pericarditis Drugs Market to Reach US$ 6.96 Billion by 2034 at 5.6%...

أضاف وظيفة جديدة Health

2026-10-26 13:26:39 - ترجمة -

Pericarditis Drugs Market to Reach US$ 6.96 Billion by 2034 at 5.6% CAGR

The global pericarditis drugs market is led by NSAIDs, colchicine, and corticosteroids, which remain first-line therapy for most patients. Arcalyst (rilonacept), the first FDA-approved IL-1 blocker for recurrent pericarditis, has opened a premium biologics segment. North America leads in revenue, while Europe and Asia-Pacific are growing as diagnosis improves. Pipeline candidates are expected...

0 التعليقات 0 المشاركات 10 مشاهدة 0 معاينة